Annual CFO
-$10.75 M
+$1.38 M+11.38%
December 1, 2023
Summary
- As of February 7, 2025, PHIO annual cash flow from operations is -$10.75 million, with the most recent change of +$1.38 million (+11.38%) on December 1, 2023.
- During the last 3 years, PHIO annual CFO has fallen by -$1.95 million (-22.12%).
- PHIO annual CFO is now -112.35% below its all-time high of -$5.06 million, reached on December 31, 2012.
Performance
PHIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.95 M
-$176.00 K-9.90%
September 1, 2024
Summary
- As of February 7, 2025, PHIO quarterly cash flow from operations is -$1.95 million, with the most recent change of -$176.00 thousand (-9.90%) on September 1, 2024.
- Over the past year, PHIO quarterly CFO has increased by +$947.00 thousand (+32.66%).
- PHIO quarterly CFO is now -73.14% below its all-time high of -$1.13 million, reached on March 31, 2013.
Performance
PHIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$8.11 M
+$947.00 K+10.45%
September 1, 2024
Summary
- As of February 7, 2025, PHIO TTM cash flow from operations is -$8.11 million, with the most recent change of +$947.00 thousand (+10.45%) on September 1, 2024.
- Over the past year, PHIO TTM CFO has increased by +$2.97 million (+26.82%).
- PHIO TTM CFO is now -167.96% below its all-time high of -$3.03 million, reached on March 31, 2011.
Performance
PHIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PHIO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | +32.7% | +26.8% |
| 3 y3 years | -22.1% | +32.7% | +26.8% |
| 5 y5 years | -42.9% | +32.7% | +26.8% |
PHIO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.4% | -9.9% | +44.6% | at high | +33.1% |
| 5 y | 5-year | -24.3% | +11.4% | -9.9% | +44.6% | at high | +33.1% |
| alltime | all time | -112.3% | +11.4% | -73.1% | +44.6% | -168.0% | +33.1% |
Phio Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.95 M(+9.9%) | -$8.11 M(-10.5%) |
| Jun 2024 | - | -$1.78 M(-11.6%) | -$9.06 M(-9.9%) |
| Mar 2024 | - | -$2.01 M(-15.1%) | -$10.05 M(-6.5%) |
| Dec 2023 | -$10.75 M(-11.4%) | -$2.37 M(-18.3%) | -$10.75 M(-3.0%) |
| Sep 2023 | - | -$2.90 M(+4.7%) | -$11.08 M(-5.3%) |
| Jun 2023 | - | -$2.77 M(+2.3%) | -$11.71 M(+3.0%) |
| Mar 2023 | - | -$2.71 M(+0.1%) | -$11.37 M(-6.3%) |
| Dec 2022 | -$12.13 M(+2.3%) | -$2.71 M(-23.3%) | -$12.13 M(+2.0%) |
| Sep 2022 | - | -$3.53 M(+45.2%) | -$11.89 M(+5.9%) |
| Jun 2022 | - | -$2.43 M(-30.0%) | -$11.23 M(-6.8%) |
| Mar 2022 | - | -$3.47 M(+40.4%) | -$12.06 M(+1.7%) |
| Dec 2021 | -$11.86 M(+34.7%) | -$2.47 M(-13.8%) | -$11.86 M(-1.3%) |
| Sep 2021 | - | -$2.87 M(-12.0%) | -$12.01 M(+8.1%) |
| Jun 2021 | - | -$3.25 M(-0.3%) | -$11.12 M(+12.4%) |
| Mar 2021 | - | -$3.27 M(+24.5%) | -$9.89 M(+12.4%) |
| Dec 2020 | -$8.80 M(+1.8%) | -$2.62 M(+33.1%) | -$8.80 M(+0.9%) |
| Sep 2020 | - | -$1.97 M(-3.0%) | -$8.72 M(-0.2%) |
| Jun 2020 | - | -$2.03 M(-6.6%) | -$8.74 M(+1.1%) |
| Mar 2020 | - | -$2.18 M(-14.5%) | -$8.65 M(+0.0%) |
| Dec 2019 | -$8.64 M(+15.0%) | -$2.55 M(+27.9%) | -$8.64 M(+10.2%) |
| Sep 2019 | - | -$1.99 M(+3.0%) | -$7.84 M(-0.2%) |
| Jun 2019 | - | -$1.93 M(-11.1%) | -$7.86 M(+0.9%) |
| Mar 2019 | - | -$2.17 M(+24.6%) | -$7.79 M(+3.6%) |
| Dec 2018 | -$7.52 M(-21.0%) | -$1.75 M(-13.0%) | -$7.52 M(-5.7%) |
| Sep 2018 | - | -$2.01 M(+7.9%) | -$7.97 M(-2.3%) |
| Jun 2018 | - | -$1.86 M(-2.5%) | -$8.16 M(-5.3%) |
| Mar 2018 | - | -$1.91 M(-13.4%) | -$8.62 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$9.51 M(+22.6%) | -$2.20 M(+0.2%) | -$9.51 M(+9.5%) |
| Sep 2017 | - | -$2.20 M(-5.2%) | -$8.69 M(+7.3%) |
| Jun 2017 | - | -$2.32 M(-17.2%) | -$8.09 M(+6.0%) |
| Mar 2017 | - | -$2.80 M(+104.0%) | -$7.63 M(-1.6%) |
| Dec 2016 | -$7.76 M(+6.1%) | -$1.37 M(-14.4%) | -$7.76 M(-2.6%) |
| Sep 2016 | - | -$1.60 M(-13.8%) | -$7.97 M(-4.3%) |
| Jun 2016 | - | -$1.86 M(-36.4%) | -$8.33 M(+0.7%) |
| Mar 2016 | - | -$2.92 M(+84.9%) | -$8.27 M(+13.0%) |
| Dec 2015 | -$7.32 M(-5.7%) | -$1.58 M(-19.4%) | -$7.32 M(-0.2%) |
| Sep 2015 | - | -$1.96 M(+9.1%) | -$7.33 M(+2.8%) |
| Jun 2015 | - | -$1.80 M(-8.7%) | -$7.13 M(-3.0%) |
| Mar 2015 | - | -$1.97 M(+23.6%) | -$7.35 M(-5.3%) |
| Dec 2014 | -$7.76 M(+22.9%) | -$1.59 M(-9.7%) | -$7.76 M(+2.6%) |
| Sep 2014 | - | -$1.77 M(-12.4%) | -$7.57 M(+0.5%) |
| Jun 2014 | - | -$2.02 M(-15.3%) | -$7.52 M(-0.5%) |
| Mar 2014 | - | -$2.38 M(+69.8%) | -$7.56 M(+19.8%) |
| Dec 2013 | -$6.31 M(+24.7%) | -$1.40 M(-18.7%) | -$6.31 M(+4.2%) |
| Sep 2013 | - | -$1.73 M(-16.1%) | -$6.06 M(+8.4%) |
| Jun 2013 | - | -$2.06 M(+82.3%) | -$5.59 M(+12.2%) |
| Mar 2013 | - | -$1.13 M(-1.9%) | -$4.98 M(-1.6%) |
| Dec 2012 | -$5.06 M(-49.3%) | -$1.15 M(-8.5%) | -$5.06 M(-24.7%) |
| Sep 2012 | - | -$1.26 M(-13.1%) | -$6.72 M(-11.3%) |
| Jun 2012 | - | -$1.45 M(+19.6%) | -$7.58 M(-7.2%) |
| Mar 2012 | - | -$1.21 M(-57.0%) | -$8.17 M(-18.2%) |
| Dec 2011 | -$9.99 M | -$2.81 M(+32.7%) | -$9.99 M(+39.1%) |
| Sep 2011 | - | -$2.12 M(+4.0%) | -$7.18 M(+41.8%) |
| Jun 2011 | - | -$2.04 M(-32.8%) | -$5.06 M(+67.2%) |
| Mar 2011 | - | -$3.03 M | -$3.03 M |
FAQ
- What is Phio Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual CFO year-on-year change?
- What is Phio Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly CFO year-on-year change?
- What is Phio Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals TTM CFO year-on-year change?
What is Phio Pharmaceuticals annual cash flow from operations?
The current annual CFO of PHIO is -$10.75 M
What is the all time high annual CFO for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual cash flow from operations is -$5.06 M
What is Phio Pharmaceuticals annual CFO year-on-year change?
Over the past year, PHIO annual cash flow from operations has changed by +$1.38 M (+11.38%)
What is Phio Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PHIO is -$1.95 M
What is the all time high quarterly CFO for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly cash flow from operations is -$1.13 M
What is Phio Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PHIO quarterly cash flow from operations has changed by +$947.00 K (+32.66%)
What is Phio Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PHIO is -$8.11 M
What is the all time high TTM CFO for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high TTM cash flow from operations is -$3.03 M
What is Phio Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PHIO TTM cash flow from operations has changed by +$2.97 M (+26.82%)